<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The advent of CT colonography (CTC) has generated conservative policies for the management of diminutive (&lt;5 mm) and small (6-9 mm) <z:mpath ids='MPATH_491'>polyps</z:mpath> to prevent inefficient duplication of screening tests </plain></SENT>
<SENT sid="1" pm="."><plain>The effect of not referring subcentimetric <z:mpath ids='MPATH_491'>polyps</z:mpath> for polypectomy on the efficacy of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> screening is still uncertain but depends on the natural history of diminutive and small <z:mpath ids='MPATH_491'>polyps</z:mpath>, as well as on the distribution of advanced <z:hpo ids='HP_0002664'>neoplasia</z:hpo> within these lesions </plain></SENT>
<SENT sid="2" pm="."><plain>Simulation modelling enables the efficacy and cost-effectiveness of conservative strategies for the management of subcentimetric lesions to be tested (such as nonreferral to polypectomy for diminutive <z:mpath ids='MPATH_491'>polyps</z:mpath> and early CTC surveillance for small <z:mpath ids='MPATH_491'>polyps</z:mpath>) </plain></SENT>
<SENT sid="3" pm="."><plain>These policies might be further refined by the inclusion of patient and <z:mpath ids='MPATH_491'>polyp</z:mpath>-related predictive factors for advanced <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, enabling a patient-tailored approach for the management of these lesions </plain></SENT>
</text></document>